Published in World J Gastroenterol on January 14, 2015
Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc Natl Acad Sci U S A (1996) 2.40
The essential role of insulin-like growth factor-1 in the intestinal tropic effects of glucagon-like peptide-2 in mice. Gastroenterology (2006) 1.97
Biological actions and therapeutic potential of the glucagon-like peptides. Gastroenterology (2002) 1.96
GLP-2 receptor localizes to enteric neurons and endocrine cells expressing vasoactive peptides and mediates increased blood flow. Gastroenterology (2006) 1.55
Intestinal growth-promoting properties of glucagon-like peptide-2 in mice. Am J Physiol (1997) 1.43
Enteroendocrine localization of GLP-2 receptor expression in humans and rodents. Gastroenterology (2000) 1.31
Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome. Am J Physiol Gastrointest Liver Physiol (2004) 1.26
GLP-2 stimulates colonic growth via KGF, released by subepithelial myofibroblasts with GLP-2 receptors. Regul Pept (2005) 1.17
Bombesin and neurotensin reduce endotoxemia, intestinal oxidative stress, and apoptosis in experimental obstructive jaundice. Ann Surg (2005) 1.10
Stability of RNA isolated from macrophages depends on the removal of an RNA-degrading activity early in the extraction procedure. Biotechniques (1990) 1.03
Role of bile in intestinal barrier function and its inhibitory effect on bacterial translocation in obstructive jaundice in rats. J Surg Res (2003) 0.97
Effect of oral glutamine administration on bacterial tanslocation, endotoxemia, liver and ileal morphology, and apoptosis in rats with obstructive jaundice. World J Surg (2005) 0.96
Gut hormones, and short bowel syndrome: the enigmatic role of glucagon-like peptide-2 in the regulation of intestinal adaptation. World J Gastroenterol (2006) 0.94
Glucagon-like peptide 2 stimulates intestinal epithelial proliferation in vitro. Dig Dis Sci (2002) 0.92
Proglucagon-derived peptides in intestinal epithelial proliferation: glucagon-like peptide-2 is a major mediator of intestinal epithelial proliferation in rats. Dig Dis Sci (2001) 0.88
Acute effects of continuous infusions of glucagon-like peptide (GLP)-1, GLP-2 and the combination (GLP-1+GLP-2) on intestinal absorption in short bowel syndrome (SBS) patients. A placebo-controlled study. Regul Pept (2013) 0.87
Effect of Danshen on apoptosis and NF-κB protein expression of the intestinal mucosa of rats with severe acute pancreatitis or obstructive jaundice. Hepatobiliary Pancreat Dis Int (2010) 0.87
Mechanism of action of glucagon-like peptide-2 to increase IGF-I mRNA in intestinal subepithelial fibroblasts. Endocrinology (2010) 0.87
Alterations of intestinal immune function and regulatory effects of L-arginine in experimental severe acute pancreatitis rats. World J Gastroenterol (2005) 0.86
The HeLa cell glucagon-like peptide-2 receptor is coupled to regulation of apoptosis and ERK1/2 activation through divergent signaling pathways. Mol Endocrinol (2004) 0.86
The effect of immunonutrition on bacterial translocation, and intestinal villus atrophy in experimental obstructive jaundice. Clin Nutr (2003) 0.85
Immunoneutralization of endogenous glucagon-like peptide-2 reduces adaptive intestinal growth in diabetic rats. Regul Pept (2002) 0.83
Ghrelin and glucagon-like peptide-2 increase immediately following massive small bowel resection. Peptides (2013) 0.83
Doping control of testosterone and human chorionic gonadotrophin: a case study. Int J Sports Med (1991) 0.82
Glucagon-like peptide-2: divergent signaling pathways. J Surg Res (2004) 0.82
Glucagon-like peptide-2 (GLP-2) increases small intestinal blood flow and mucosal growth in ruminating calves. J Dairy Sci (2011) 0.82
Gastric relaxation induced by glucagon-like peptide-2 in mice fed a high-fat diet or fasted. Peptides (2011) 0.82
Does prolonged biliary obstructive jaundice sensitize the liver to endotoxemia? Shock (2009) 0.81
Effects of PEGylated porcine glucagon-like peptide-2 therapy in weaning piglets challenged with lipopolysaccharide. Peptides (2014) 0.80
Glucagon-like peptide-2 receptor activation in the rat intestinal mucosa. Endocrinology (2003) 0.80
Effects of glucagon-like peptide-2 on bacterial translocation in rat models of colitis. Turk J Gastroenterol (2012) 0.78
Enhanced gene transfer to pancreatic islets using glucagon-like peptide-1. Transplant Proc (2013) 0.77
The use of antiendotoxin peptides in obstructive jaundice endotoxemia. Eur J Gastroenterol Hepatol (2012) 0.77
[The diagnostics of the obstructive jaundice and possibilities to improve the efficacy of its miniinvasive treatment]. Khirurgiia (Mosk) (2011) 0.77
[Effect of glucagon-like peptide 2 on the intestinal mucosal immunity and correlative cytokines in mice with gut ischemia/reperfusion injury]. Zhonghua Wei Chang Wai Ke Za Zhi (2006) 0.77